Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Immutep (IMM AU)
Watchlist
23
Analysis
Health Care
•
Australia
Immutep Limited operates as a biotechnology company. The Company focuses on developing novel immunotherapy treatments for cancer and autoimmune disease. Immutep offers its services worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Immutep
•
27 Sep 2018 15:44
•
Issuer-paid
Immutep - A second big pharma collaboration for efti
Immutep has entered into a clinical trial collaboration and supply agreement with Merck/Pfizer to investigate the combination of its APC activator...
Edison Investment Research
Follow
44 Views
Share
bullish
•
Immutep
•
30 Aug 2018 18:17
•
Issuer-paid
Immutep - LAG-3 progress in-house and via partners
Immutep has reported encouraging progress from its in-house and partnered programs over the past few months. Interim data from the TACTI-mel combo...
Edison Investment Research
Follow
38 Views
Share
bullish
•
Immutep
•
30 Aug 2018 17:54
•
Issuer-paid
Immutep - LAG-3 progress in-house and via partners
Immutep has reported encouraging progress from its in-house and partnered programmes over the past few months. Interim data from the TACTI-mel...
Edison Investment Research
Follow
37 Views
Share
bullish
•
Immutep
•
29 Mar 2018 18:16
•
Issuer-paid
Immutep - Merck collaboration opens new opportunities
Immutep has entered a clinical trial collaboration and supply agreement with Merck & Co (MSD) for a Phase II study to evaluate eftilagimod...
Edison Investment Research
Follow
60 Views
Share
bullish
•
Immutep
•
29 Mar 2018 16:46
•
Issuer-paid
Immutep - Merck collaboration opens new opportunities
Immutep has entered a clinical trial collaboration and supply agreement with Merck & Co (MSD) for a Phase II study to evaluate eftilagimod...
Edison Investment Research
Follow
67 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.36.0
x